Search Market Research Report
Substance (Drug) Abuse Treatment Market Size, Share Global Analysis Report, 2022 – 2030
Substance (Drug) Abuse Treatment Market Size, Share, Growth Analysis Report By Type (Nicotine Addiction, Alcohol Addiction, and Drug Abuse Treatment), By Distribution Channel (Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Others), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2030
Industry Insights
[215+ Pages Report] According to the report published by Facts and Factors, the global substance (drug) abuse treatment market size was worth around USD 10.25 billion in 2021 and is predicted to grow to around USD 22.9 billion by 2030 with a compound annual growth rate (CAGR) of roughly 8.49% between 2022 and 2030. The report analyzes the global substance (drug) abuse treatment market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the substance (drug) abuse treatment market.
Market Overview
Substance abuse, which includes alcohol and other types of drugs, in medical terms is used while describing a certain pattern consisting of drug or substance consumption that is not beneficial to health and can cause distress or significant problems. The issues arising due to substance abuse can mean missing out on work or school days or using the products in dangerous situations like swimming or driving a car. It can lead to multiple types of problems which are not just restricted to health but other areas of quality life as well including problems with the family, finances, and colleagues. Substance (drug) abuse can also lead people into legal problems which can damage the entire life of the individuals consuming the substances in uncontrolled quantities.
Key Insights
- As per the analysis shared by our research analyst, the global substance (drug) abuse treatment market is estimated to grow annually at a CAGR of around 8.49% over the forecast period (2022-2030)
- In terms of revenue, the global substance (drug) abuse treatment size was valued at around USD 10.25 billion in 2021 and is projected to reach USD 22.9 billion, by 2030.
- The global substance (drug) abuse treatment market is projected to grow at a significant rate due to the growing action against substance abuse by regulatory authorities
- Based on type segmentation, alcohol addiction was predicted to show maximum market share in the year 2021
- Based on distribution channel segmentation, hospital pharmacies was the leading channel in 2021
- On the basis of region, North America was the leading revenue generator in 2021
Growth Drivers
- Growing measures undertaken by law and order regulatory bodies to drive market growth
The global substance (drug) abuse treatment market is projected to grow owing to the increasing actions and measures adopted by various international, regional, and domestic law & order regulatory bodies across the globe. Substance abuse is one of the primary concerns in the modern world where drugs and other substances have become easily accessible. Substance abuse not only impacts the personal lives of the individual involved but eventually, it can affect the entire society and its growth. Abuse of alcohol and drugs is a leading cause of social issues like child abuse, increase in crime rates, child neglect, hospitalizations, and rapidly reducing public healthcare funds. As per statistics submitted by the National Institute of Drug Abuse, more than 85% of the population in prison have ongoing substance abuse problems or were imprisoned for reasons related to drug abuse.
Restraints
- Understanding grass-root reasons for substance abuse to restrict market expansion
Substance (drug) abuse cannot be easily classified into segments related to reasons or solutions. It is an extremely personal disorder and the cause for substance abuse may vary from one person to another. This aspect of substance abuse makes it difficult to issue a standard treatment plan since it is important to first understand the main reason why a person started depending on drugs to a scale where it has become an uncontrolled habit part of life. The substance abuse problem may begin on a small scale and there is no timeline for understanding how long it takes for the issue to become a stubborn issue.
Opportunities
- Growing use of technology to manage substance abuse cases to provide expansion opportunities
Social media has a major role to play in shaping the future world. It has become an essential tool that can help create awareness against bad influences as well as keep track of people who may be involved in such a business. For instance, in 2017, the Drug Enforcement Agency used a fake Instagram account to nab a person selling illicit drugs in the USA. Such arrests can help law agencies to track the buyers of drugs and extend a helping hand to youngsters or adults who may be finding it difficult to come out of their substance addiction problems.
Challenges
- Negative connotation related to substance abuse to challenge market growth
Substance abuse is a problem that people refrain from talking about either for personal issues or if a family member or friend is suffering from the problem. This is because, in many areas, substance abuse has negative connotations around it which makes people uncomfortable and leads to a set of affected populations living in denial. Changing the approach toward handling cases of substance abuse is a major challenge that the global market players face.
Segmentation Analysis
The global substance (drug) abuse treatment market is segmented based on type, distribution channel, and region
Based on type, the global market divisions are nicotine addiction, alcohol addiction, and drug abuse treatment. The global market was dominated by the alcohol addiction segment in 2021 due to more people consuming uncontrolled amounts of alcoholic drinks as compared to nicotine and drug addiction. A large section of the population gets exposed to alcohol from a young age because these drinks are more easily available in the open market as opposed to hard drugs. The sale of alcohol is legal in most countries which adds to the growing list of people suffering from alcohol addiction. As per estimates, annually, over 12.9% of the US population suffers from alcohol abuse disorder.
Based on distribution channel, the global market divisions are drug stores & retail pharmacies, hospital pharmacies, and others. The global market was dominated by the hospital pharmacies segment in 2021 due to an increase in the number of prescription-based treatment plans and medicines as well as the growing availability of certified physicians and the guidance provided by them to treat substance abuse. More than 50% of the segmental revenue was generated by the hospital pharmacies in the last year since they were the preferred choice of medicinal drug distribution as they are more reliable.
Recent Developments:
- In December 2022, the National Institute of Health (NIH), USA, established a new network of research that is expected to help test various harm reduction strategies in different community-based settings. This research network is the largest funding provided by the NIH since its inception
- In October 2021, the Kerala Government in India launched a new project intended to help students stay away from drugs. The project is initiated by the Excise Department of Kerala and is called the Vimukti Mission
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 10.25 Billion |
Projected Market Size in 2030 |
USD 22.9 Billion |
CAGR Growth Rate |
8.49% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2030 |
Key Market Players |
Teva Pharmaceutical Industries Ltd., Noramco, Pfizer Inc., Glenmark Pharmaceuticals Ltd., GlaxoSmithKline plc, Allergan plc, BioCorRx Inc., and others. |
Key Segment |
By Type, Distribution Channel, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Regional Analysis
- North America to lead with the highest market growth
The global substance (drug) abuse treatment market is anticipated to be dominated by North America during the forecast period due to the intensive measures of the regional governments of the USA and Canada against the substance abuse problem. A 2019 report submitted in the National Survey on Drug Use and Health mentioned that more than 85% of the surveyed people above the age of 18 years, in the USA, had consumed alcohol at some point in their life. Colombia, with its insular regions in the North American region, is the largest producer of cocaine in the world.
As estimated, more than 14,000 metric tons of coca leaves are produced in the country which accounts for over 80% of the global supply. It is also the largest supplier of harmful drugs. The Centers for Disease Control and Prevention stated that around 107,622 cases of death induced by overdose were reported in 2021 in the US which is a jump of 15% from the number in 2020. Opioid overdose is considered a public health crisis in the country, with Baltimore city leading with the highest number of opioid addiction cases.
Competitive Analysis
- Teva Pharmaceutical Industries Ltd.
- Noramco
- Pfizer Inc.
- Glenmark Pharmaceuticals Ltd.
- GlaxoSmithKline plc
- Allergan plc
- BioCorRx Inc.
The global substance (drug) abuse treatment market is segmented as follows:
By Type Segment Analysis
- Nicotine Addiction
- Alcohol Addiction
- Drug Abuse Treatment
By Distribution Channel Segment Analysis
- Drug Stores
- Retail Pharmacies
- Hospital Pharmacies
- Others
By Regional Segment Analysis
- North America
- The U.S.
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Content
Industry Major Market Players
- Teva Pharmaceutical Industries Ltd.
- Noramco
- Pfizer Inc.
- Glenmark Pharmaceuticals Ltd.
- GlaxoSmithKline plc
- Allergan plc
- BioCorRx Inc.
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors